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Monkeypox is a rare viral zoonotic disease; primary infec-
tions are reported from remote forest areas of Central and 
West Africa. We report an investigation of a monkeypox 
outbreak in Lobaye, southwest Central African Republic, in 
October 2018.
Monkeypox, a zoonotic disease caused by an Ortho-poxvirus, has clinical signs and symptoms in humans 
similar to smallpox and a case-fatality rate of 10% (1). The 
specific reservoir species for monkeypox virus remains, to 
a large extent, unidentified (2). Spillover events of mon-
keypox have been reported in remote forest areas of Central 
and West Africa. After zoonotic infection, the virus can be 
transmitted from person to person (1).
To date, human monkeypox outbreaks in the Central Af-
rican Republic (CAR) have been small: ≈10 cases, restricted 
to a family or village. Primary infection in these outbreaks oc-
curred from contact with wild fauna, with secondary transmis-
sion among close contacts in the community (3,4) and limited 
nosocomial transmission (5). Since 2000, the Virology Labo-
ratory of the Institut Pasteur de Bangui (IP Bangui), a regional 
reference center for monkeypox, has reported 20 monkeypox 
outbreaks across several regions of CAR, totaling ≈100 cases, 
particularly in the region of Lobaye (3,4). In 2018 alone, IP 
Bangui investigated 6 different outbreaks in CAR, indicating 
a possible increase in frequency of outbreaks (6,7).
On September 27, 2018, a healthcare worker from Zo-
mea Kaka healthcare center in Lobaye reported to IP Bangui 
about 3 cases of suspected monkeypox in an Aka Pygmy 
family. A 25-year-old female sought care at the health cen-
ter, 10 km from her village, for maculopapular rash and le-
sions. She was afebrile. Her signs and symptoms indicated 
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resolving late stage monkeypox infection. She was accom-
panied by her 2 daughters, 5 months and 4 years of age, both 
showing typical symptoms of active monkeypox infection, 
notably maculopapular rash on the palms of their hands and 
soles of their feet (Appendix Figure, http://wwwnc.cdc.gov/
EID/article/25/8/19-0112-App1.pdf). Blood or pus samples 
taken from the 3 patients were confirmed positive for mon-
keypox infection by PCR on September 29 (8) (Appendix).
On October 5, IP Bangui carried out an investigation 
among contacts of the index case-patient, in collaboration 
with the Ministry of Health and the World Health Organiza-
tion CAR Country Office. The index case-patient reported 
butchering 3 small mammals known in local Aka language 
as Yabo (African civet, Civettictis civetta), Gbè (Emin’s 
pouched rat, Cricetomys emini), and Sende (African rope 
squirrel, Funesciurus anerythrus). She butchered 1 of each 
in a forested area 2 weeks before the onset of rash.
During October 6–10, two additional family contacts 
from the village, the index case-patient’s 2 sisters, 7 and 16 
years of age, reported symptoms consistent with monkeypox 
infection. Healthcare workers collected blood or pus samples 
from the patients, and IP Bangui confirmed monkeypox in-
fection by PCR. On October 26, monkeypox infection was 
confirmed in another family contact, the index case-patient’s 
33-year-old sister-in-law. The dates of the onset of symptoms 
suggest 3 waves of intrafamilial transmission (Table) (9).
IP Bangui conducted further investigations by using 
Orthopoxvirus serologic assays (Appendix) on blood sam-
ples collected from 2 healthcare worker contacts on Octo-
ber 5 and from 31 village contacts on October 25. Results 
revealed evidence of Orthopoxvirus serologic response in 
the index case-patient’s mother; 2 healthcare workers who 
had cared for the index case-patient; and the index case-
patient’s brother, who brought her the wild animals (Table).
Serologic evidence of possible monkeypox infection 
can indicate prior exposure to the virus or, among per-
sons >38 years of age, immunization against smallpox, 
and might explain the restricted size of the outbreak in the 
village. However, smallpox vaccination campaigns with a 
live-attenuated vaccinia virus ended in 1979 in CAR. Con-
sequently, an increasingly larger proportion of the popula-
tion is immunologically naive to Orthopoxvirus infection.
This investigation identified 5 clinical cases of sec-
ondary monkeypox infection spread over 3 waves of 
intrafamilial infection, originating from an index case-
patient with primary infection possibly attributable to 
contact with wild fauna. The prompt declaration and iso-
lation of suspected cases, as well as possible naturally 
 
Table. Molecular and serologic evidence of index case-patient and contacts with known and possible exposure to monkeypox virus, 
Central African Republic, 2018* 
Patients 
Age, 
y/sex 
Symptom 
onset date 
Signs/ 
symptoms 
Animal 
contact 
Collection 
date 
Sample type 
 
PCR‡   IgG§ Smallpox 
vaccine¶ Blood Pus† MPXV CPXV  MPXV CPXV 
Index case-
patient 
25/F 2018 Sep 
8 
Rash, 
lesions 
Y 2018 Sep 
27 
Y N  + –  – – N 
Contacts               
 Daughter 0.4/F 2018 Sep 
20 
Fever, 
rash, 
lesions 
N 2018 Sep 
27 
N Y  + –  ND ND N 
 Daughter 4/F 2018 Sep 
26 
Fever, 
rash, 
lesions 
N 2018 Sep 
27 
Y N  + –  – – N 
 Sister 16/F 2018 Oct 6 Rash, 
lesions 
N 2018 Oct 8 N Y  + –  ND ND N 
 Sister 7/F 2018 Oct 9 Rash, 
lesions 
N 2018 Oct 
11 
Y N  + –  – – N 
 SIL 33/F 2018 Oct 
24 
Rash, 
lesions 
N 2018 Oct 
25 
Y N  + –  – – N 
 Mother 49/F NA None N 2018 Oct 5 Y N  ND ND  + + Y 
 Son 13/M NA None Y 2018 Oct 5 Y N  ND ND  – – N 
 Brother 49/M NA None Y 2018 Oct 
25 
Y N  ND ND  + – Y 
 Brother  
 of SIL 
8/M NA None NK 2018 Oct 
25 
Y N  ND ND  + + N 
 Nephew  
 of SIL 
13/M NA None NK 2018 Oct 
25 
Y N  ND ND  – – N 
 HCW 34/M NA None N 2018 Oct 5 Y N  ND ND  + + N 
 HCW 45/F NA None N 2018 Oct 5 Y N  ND ND  + + Y 
 Social  
 contact 
22/F NA None NK 2018 Oct 
25 
Y N  ND ND  + – N 
*A total of 33 contacts were tested, 2 HCWs and 31 village contacts. CPXV, cowpox virus; HCW, healthcare worker; MPXV, monkeypox virus; NA, not 
applicable; ND, not done; NK, not known; SIL, sister-in-law; +, positive; –, negative. 
†Samples obtained by HCWs after training on collecting swab samples. 
‡Quantitative and conventional PCR were performed by using generic primers G2R-G and Congo Basin primers C3L (8). 
§In-house tests were performed by using MPXV antigen isolated from local human cases and CPXV antigen related to Brighton Red strain. 
¶History of smallpox vaccination was determined by verbal report and presence of scar. 
 
1604 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 25, No. 8, August 2019
RESEARCH LETTERS
acquired immunity or persistence of vaccine-derived 
immunity within the community, likely contributed to 
the restricted extent of secondary transmission. Further 
studies are needed to clarify risk factors for primary and 
secondary monkeypox transmission.
Positive serologic findings in healthcare workers during 
this investigation also highlight the limited infection preven-
tion and control resources, such as isolation rooms, gowns, 
gloves, N95 respirators, and goggles, to protect healthcare 
workers responding to outbreaks in CAR. For communities 
located in remote forest areas in which zoonotic spillover and 
secondary transmission are thought to occur regularly, health 
center capacity and resources need to be strengthened. Health 
centers urgently need training on case recognition for health-
care workers, access to diagnostic capacities, and appropriate 
infection prevention and control measures to reduce the pos-
sibility of secondary transmission in these areas (10).
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Whether Mycobacterium leprae transmits from placenta to 
fetus remains unknown. We describe the case of a pregnant 
woman with untreated histoid leproma. Although her new-
born was healthy, laboratory examination revealed intact M. 
leprae present in the placenta, suggesting that the placental 
barrier might prevent vertical dissemination of M. leprae.
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